Improving bone graft healing with engineered tissue
Tissue Engineering Strategies to Revitalize Allografts
This study is working on a new way to help bone grafts heal better after surgeries for things like injuries or cancer, using a special gel with stem cells and proteins to make the healing process more effective.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oregon NIH-funded |
| Lab location | 1 site (Eugene, United States) |
| Project ID | NIH-10830613 on NIH RePORTER |
What this research studies
This research focuses on enhancing the healing process of bone grafts used in surgeries for congenital defects, trauma, infections, and cancer removal. The team is developing a tissue-engineered periosteum that mimics the natural tissue surrounding bones, which is crucial for successful integration and healing. By incorporating stem cells and specific proteins into a hydrogel that surrounds the graft, they aim to significantly improve the success rates of allografts, which currently face high failure rates due to inadequate healing. The approach involves innovative materials and biological cues to promote better bone regeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals requiring bone grafts due to congenital anomalies, trauma, infections, or cancer-related surgeries.
Not a fit: Patients who do not require bone grafts or have conditions unrelated to bone healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective bone grafts with higher success rates, reducing the need for repeat surgeries.
How similar studies have performed: Previous research has shown promise in using tissue engineering approaches for improving graft integration, indicating potential success for this novel method.
Where this research is happening
Eugene, United States
- University of Oregon — Eugene, United States (Active)
Researchers
- Principal investigator: Benoit, Danielle S. — University of Oregon
- Study coordinator: Benoit, Danielle S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.